Experts have been exploring the relationship between Mycobacterium leprae, a bacteria which causes leprosy, and the formation of the membrane attack complex (MAC), which is a tool deployed by the innate immune system to fight pathogens. MAC can damage adjacent health tissues and trigger inflammation at the early stages of the disease.
However, new research shows that inhibition of MAC formation reduces nerve damage and improves regeneration and functional recovery.
It is also suggested that biomarkers could be used to study the mechanism of autonomic neuropathy in general, with the aim of new drug development for autoimmune diseases such as diabetes, rheumatoid arthritis and lupus.
The research team consisted of Professor Pranab K. Das from the University of Birmingham and academics from the Institute of Lauro Souza Lima (ILSL) in Bauru, São Paulo, Brazil – where the research was carried out – along with the Academic Medical Center at the University of Amsterdam, Netherlands.
Professor Pranab K. Das, Honorary Senior Research Fellow, University of Birmingham said:
‘Our new research shows that inflammatory reactions can be prevented at an early stage of the disease, reducing the risk of the nerve damage that leads to the disabilities caused by leprosy. We propose that MAC inhibition could form the basis of the future development of novel therapeutics from leprosy.’
Despite a marked decline in the number of cases of leprosy since the 1980s and effective multidrug therapy (MDT), the disease remains endemic in several countries, including Brazil, where it is known as Hansen’s disease. Almost 35,000 new cases of the disease were detected in Brazil during 2013, meaning that after India, it is the country where the disease is most prevalent worldwide.
Professor Das warns that the fall in new case detection doesn’t mean that the disease is becoming less of a public health problem globally:
‘Our research has shown that fewer people have been diagnosed with leprosy in Brazil due to the decline in clinical knowledge about the disease, which, coupled with its long incubation period, leads to delays in diagnosis after the onset of the disease. Furthermore, the stigma attached to those who have leprosy prevents many coming forward for treatment at the earliest stage.
‘The UK and Brazilian governments are now encouraging collaborative studies on neglected tropical diseases and I hope, going forward, we can initiate further research on leprosy, inflammation and nerve damage.’
Notes to Editors
For interview requests or for more information, please contact Ben Goodwin, International Media Relations Manager, University of Birmingham on +44 (0) 121 414 8254
For out of hours media enquiries, please call: +44 (0) 7789 921 165
Original research: Nawal Bahia El Idrissi, Pranab K. Das, Kees Fluiter, Patricia S. Rosa, Jeroen Vreijling, Dirk Troost, B. Paul Morgan, Frank Baas and Valeria Ramaglia (2015) ‘M. leprae components induce nerve damage by complement activation: identification of lipoarabinomannan as the dominant complement activator’. Acta Neuropathologica, DOI: 10.1007/s00401-015-1404-5
- Autonomic neuropathy is a group of symptoms which occur when there is damage to the nerves that manage everyday functions such as blood pressure, heart rate and digestion. These symptoms vary according to the nerves affected but examples include shortness of breath, swollen abdomen, nausea and abnormal sweating.
- The University of Birmingham is ranked amongst the world’s top 100 institutions, its work brings people from across the world to Birmingham, including researchers and teachers and more than 6,000 international students from nearly 150 countries.